Design, synthesis and preliminary biological evaluation of rivastigmine-INDY hybrids as multitarget ligands against Alzheimer's disease

targeting butyrylcholinesterase and DYRK1ACLK1 kinases

★ 5.0 · 58 reads

Request Code
ZLIB.IO18508865
Published
2022
Pages
1
Language
Unknown